Physician profile
John Young
NPI 1578572392
$3,248.29
in general payments reported to CMS, 2019-2025
20 companies · $354 in 2025
The $354 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $83.48 · 2021: $672 · 2022: $796 · 2023: $727 · 2024: $408 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $742.16 | 2021-2024 | Dyanavel Xr, Quillivant |
| Corium, LLC | $738.03 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $414.83 | 2022-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $262.40 | 2022-2025 | Bexsero, Rotarix, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $244.39 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $230.34 | 2021-2025 | Qelbree |
| Kowa Pharmaceuticals America, INC. | $102.97 | 2025 | Zoryve |
| Abbvie INC. | $85.81 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $82.94 | 2019-2024 | Vaqta, Gardasil 9, Gardasil |
| Collegium Pharmaceutical, INC. | $78.80 | 2025 | Jornay Pm |
| Seqirus USA INC | $51.25 | 2024-2025 | Flucelvax |
| Pfizer INC. | $43.67 | 2019-2023 | |
| Sanofi Pasteur INC. | $43.24 | 2020-2025 | |
| Sobi, INC | $23.26 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.66 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $17.79 | 2025 | Daybue |
| Novartis Pharmaceuticals Corporation | $17.42 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.24 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.68 | 2020 | |
| Shire North American Group INC | $16.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.